We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Largest Scanner Ever Developed to Produce Faster, More Sensitive Images

By Biotechdaily staff writers
Posted on 03 Mar 2008
One of the world's largest imagers has been developed that could form the basis of future medical scanners. More...
The new technology will allow clinicians to produce more sensitive and faster images of the human body at a lower cost to healthcare professionals.

The innovative technology, which has been developed by engineers from the University of Sheffield (UK) and Science & Technology Facilities Council (STFC) Rutherford-Appleton Laboratories (Didcot, UK), as part of the £4.5m Basic Technology MI-3 Consortium, will help in providing instant analysis of medical screening tests and the early detection of cancer.

Easier to use and faster than the imagers used in current body scanners, and with very large active pixel sensors with an imaging area of approximately 6-cm2, the technology has been specifically developed to meet demanding clinical applications such as X-ray imaging and mammography. This silicon imager is approximately 15 times larger in area than the latest Intel processors.

The next step of the project is to produce wafer-scale imagers that can produce images approaching the width of the human torso. This will eliminate the need for expensive and inefficient lenses and in that way enable lower-cost, more sensitive, and faster medical imaging systems.

Prof. Nigel Allinson, from the University of Sheffield's Vision and Information Engineering Group in the department of electronic and electrical engineering and who led the project, said, "Very large active pixel sensors could soon be making a major impact on medical imaging by further reducing the need for the old technology of film. The UK is a world-lead in such sensors for scientific and medical applications, and this is a lead we intend to maintain.”

Dr. Renato Turchetta, leader of the design team, added, "Wafer-scale CMOS [complementary metal oxide semiconductor] sensors are now a reality and the team is ready to take the digital revolution a step further in order to revolutionize scientific and medical imaging.”

MI-3 is a four-year £4.5 million project funded by the UK Research Council Basic Technology program. The consortium consists of leading groups in detector technology, microelectronics, particle physics, space science, biosciences, and medical physics at universities throughout the United Kingdom.

These sensors were developed by the CMOS Sensor Design Group at STFC's Rutherford Appleton Laboratory in association with the University of Sheffield and University College London.


Related Links:
University of Sheffield
Science & Technology Facilities Council Rutherford-Appleton Laboratories

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.